TPVG

TPVG is a venture-debt BDC whose stock ($4.92) trades at roughly 0.56x its ~$8.74 book value per share (equity $354M / 40.5M shares) — a ~44% discount that already prices in real distress, not a quiet compounder. The apparent cheapness (P/E 4.7, ROE 13.9%, net income $49.2M up 53.6%) is the value case; the discount and the history are the warning. Net income has whipsawed from +$76.6M (2021) to losses of -$20.1M and -$39.8M (2022-2023) before recovering to +$32.0M and +$49.2M — that swing is fair-value markdowns on a portfolio the 10-K explicitly says is 'concentrated in technology and other high growth industries' and 'venture capital-backed companies,' recorded at Board-determined fair value 'as a result, there is uncertainty as to the value of our portfolio.' A market putting a BDC at 0.56x NAV is usually forecasting further NAV erosion and a distribution cut, and the filing's own risk summary — 'the amount and frequency of any distributions we may make is uncertain… you may not receive distributions or our distributions may not grow' — validates that fear.

The balance sheet and cash trajectory reinforce caution. Operating cash flow was -$57.0M (fundings net of prepayments), cash fell 55.6% to $20.4M, and the company leaned on debt — long-term debt up 17.6% to $464M, Credit Facility borrowings jumping from $5.0M to $95.0M, funding $41.3M of distributions partly out of borrowings and new 8.11% 2028 Notes. Liabilities/equity of 1.37x is inside BDC limits, but the accumulated deficit of -$161M and the negative EPS-vs-net-income divergence (diluted EPS $1.05 down 25% even as GAAP net income rose) signal that headline profit is being flattered by non-cash marks rather than clean spread income covering the payout.